New diabetes clinical trial: A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Published on: May 10, 2025 at 11:00PM
Conditions: Obesity; Overweight; Overweight With One Weight Related Comorbidity
Interventions: Drug: RO7204239; Drug: RO7204239 Matching Placebo; Drug: Tirzepatide
Sponsors: Hoffmann-La Roche
Recruiting
https://ift.tt/WjfZcgH